KYMR | REGN | SNY | SNYNF | Terry Chrisomalis Kymera: Positive Phase 1 KT-621 Study Leads To Q4 2025 AD Treatment Data ByMario Cazombo June 2, 2025
SNY | SNYNF | Stephen Ayers Sanofi: Finding Value In The Wake Of Itepekimab’s Disappointment ByMario Cazombo May 31, 2025
GCVRZ | ONeil Trader | REGN | SNY | SNYNF | VRNA Itepekimab Failure A Setback For Sanofi And Regeneron ByMario Cazombo May 30, 2025
AMSSY | AUKUF | BAYZF | BBRYF | BKRIF | CIXPF | GSK | ING | JSNSF | Mutual Fund Commentaries | NOK | NOKBF | Pzena Investment Management | SNY | SNYNF | TPRKY | TVPKF Pzena European Focused Value Q1 2025 Commentary ByMario Cazombo May 27, 2025
